Cargando…

Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease

Mass effect from polycystic kidney and liver enlargement can result in significant clinical complications and symptoms in autosomal dominant polycystic kidney disease (ADPKD). In this single-center study, we examined the correlation of height-adjusted total liver volume (htTLV) and total kidney volu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyunsuk, Park, Hayne Cho, Ryu, Hyunjin, Kim, Kiwon, Kim, Hyo Sang, Oh, Kook-Hwan, Yu, Su Jong, Chung, Jin Wook, Cho, Jeong Yeon, Kim, Seung Hyup, Cheong, Hae Il, Lee, Kyubeck, Park, Jong Hoon, Pei, York, Hwang, Young-Hwan, Ahn, Curie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671651/ https://www.ncbi.nlm.nih.gov/pubmed/26641645 http://dx.doi.org/10.1371/journal.pone.0144526

Ejemplares similares

Expression and secretion of CXCL12 are enhanced in autosomal dominant polycystic kidney disease
por: Kim, Hyunho, et al.
Publicado: (2019)

Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease
por: Han, Miyeun, et al.
Publicado: (2014)

Bioelectrical impedance analysis as a nutritional assessment tool in Autosomal Dominant Polycystic Kidney Disease
por: Ryu, Hyunjin, et al.
Publicado: (2019)

Total kidney and liver volume is a major risk factor for malnutrition in ambulatory patients with autosomal dominant polycystic kidney disease
por: Ryu, Hyunjin, et al.
Publicado: (2017)

Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients
por: Park, Hayne Cho, et al.
Publicado: (2015)

Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients
por: Oh, Yun Kyu, et al.
Publicado: (2021)

Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing
por: Kim, Hyunsuk, et al.
Publicado: (2019)

Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease
por: Park, Hayne Cho, et al.
Publicado: (2020)

Author Correction: Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing
por: Kim, Hyunsuk, et al.
Publicado: (2020)

Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Kim, Yaerim, et al.
Publicado: (2023)

Successfully Treated Escherichia coli-Induced Emphysematous Cyst Infection with Combination of Intravenous Antibiotics and Intracystic Antibiotics Irrigation in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Kim, Hyunsuk, et al.
Publicado: (2013)

Transcatheter Arterial Embolization Therapy for a Massive Polycystic Liver in Autosomal Dominant Polycystic Kidney Disease Patients
por: Park, Hayne Cho, et al.
Publicado: (2009)

Identification of novel PKD1 and PKD2 mutations in Korean patients with autosomal dominant polycystic kidney disease
por: Choi, Rihwa, et al.
Publicado: (2014)

Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study
por: Park, Hayne Cho, et al.
Publicado: (2012)

Xp11.2 translocation renal cell carcinoma in the autosomal dominant polycystic kidney disease patient with preserved renal function
por: Huh, Hyuk, et al.
Publicado: (2017)

Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study
por: Park, Hayne Cho, et al.
Publicado: (2022)

Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease
por: Hwang, Jin Ho, et al.
Publicado: (2013)

Esophageal Artery Pseudoaneurysm and Takayasu Arteritis in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Kim, Hyunsuk, et al.
Publicado: (2018)

Synergistic Antiproliferative Effects of All-Trans Retinoic Acid and Paclitaxel on Autosomal Dominant Polycystic Kidney Disease Epithelial Cells
por: Nguyen, Que Thanh Thanh, et al.
Publicado: (2021)

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period
por: Huh, Hyuk, et al.
Publicado: (2023)

Multiple Cardiovascular Manifestations in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Kang, Young Ran, et al.
Publicado: (2014)

Obturator hernia in autosomal dominant polycystic kidney disease
por: Jung, Jong Hwan, et al.
Publicado: (2018)

Comprehensive analysis of mutations of renal cell carcinoma in an autosomal dominant polycystic kidney disease patient
por: Shim, Kwang Eon, et al.
Publicado: (2020)

Polycystin-1 Expression in Fetal, Adult and Autosomal Dominant Polycystic Kidney
por: Chae, Seoung Wan, et al.
Publicado: (2006)

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression
por: Kim, Hyunsuk, et al.
Publicado: (2022)

Cyst Ablation Using a Mixture of N-Butyl Cyanoacrylate and Iodized Oil in Patients with Autosomal Dominant Polycystic Kidney Disease: the Long-Term Results
por: Kim, See Hyung, et al.
Publicado: (2009)

Safety and feasibility of synchronous unilateral nephrectomy and contralateral heminephrectomy for extremely severe autosomal dominant polycystic kidney disease: Techniques and outcome
por: Han, Jang Hee, et al.
Publicado: (2022)

Feasibility of artificial intelligence-based decision supporting system in tolvaptan prescription for autosomal dominant polycystic kidney disease
por: Shin, Jung Hyun, et al.
Publicado: (2023)

RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study
por: Ryu, Hyunjin, et al.
Publicado: (2020)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Laparoscopic biopsy-proven lupus nephritis in autosomal dominant polycystic kidney disease
por: Park, Ji In, et al.
Publicado: (2012)

Differential Expression of PKD2-Associated Genes in Autosomal Dominant Polycystic Kidney Disease
por: Yook, Yeon Joo, et al.
Publicado: (2012)

Successful Pregnancy in a Patient with Autosomal Dominant Polycystic Kidney Disease on Long-Term Hemodialysis
por: Jung, Ji Hye, et al.
Publicado: (2014)

Unilateral renal displacement in an autosomal dominant polycystic kidney disease patient
por: Kim, Jin, et al.
Publicado: (2023)

‘A sword of Damocles’: patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study
por: Logeman, Charlotte, et al.
Publicado: (2020)

Multifocal Renal Cell Carcinoma of Different Histological Subtypes in Autosomal Dominant Polycystic Kidney Disease
por: Na, Ki Yong, et al.
Publicado: (2012)

Dietary Assessment of Korean Non-dialysis Chronic Kidney Disease Patients with or without Diabetes
por: Lee, Hyesu, et al.
Publicado: (2020)

Long-term Tolvaptan Treatment of Autosomal Dominant Polycystic Kidney Disease in Korea
por: Kim, Ha Yeon, et al.
Publicado: (2018)

Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease
por: Liu, Jin, et al.
Publicado: (2022)

Infected cyst in patients with autosomal dominant polycystic kidney disease: Analysis of computed tomographic and ultrasonographic imaging features
por: Oh, Jiseon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i5v5r6alt13c5lgq2jgd1etsh9